FDA ends CSR pilot, plots new approach for disclosing study reports

FDA ends CSR pilot, plots new approach for disclosing study reports

Source: 
Endpoints
snippet: 

The FDA on Thursday officially ended a fledgling pilot program that was part of an effort to provide more transparency on the drug approval process. The agency said it’s working on a new approach to disclosing study reports.